| 产品名称 | MK 0364 - Taranabant |
| 产品货号 | Axon 1550 CAS [701977-09-5] MF C27H25ClF3N3O2MW 515.95 Purity: 98% Optical purity: Optically pure Soluble in DMSO Description Potent and selective cannabinoid receptor type 1 (CB1) antagonist and/or inverse agonist References Certificates Categories Extra info TM Fong et al. Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, MK-0364, in rodents. J. Pharmacol. Exp. Ther. 2007, 321(3), 1013-1022. MS Kipnes et al. A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes. Diabetes, Obesity & Metabolism 2010, 12 (6), 517–31. Certificate of Analysis Material Safety Data Sheet Cardiovascular CNS Diabetes & Metabolism Pain & Inflammation CB1 A13 CB1 antagonist/inverse agonist Chemical name N-[(1S,2S)-3-(4-Chloro-phenyl)-2-(3-cyano-phenyl)-1-methyl-propyl]-2-methyl-2-(5-trifluoromethyl-pyridin-2-yloxy)-propionamide Parent CAS No. [701977-09-5] Order Size Unit Price Stock 2 mg €95.00 In Stock |
| 产品价格 | 现货询价，电话：010-67529703 |
| 产品规格 | |
| 产品品牌 | axonmedchem |
| 产品概述 | |
| 产品详情 |
MK 0364 - TaranabantAxon 1550 CAS [701977-09-5] MF C27H25ClF3N3O2
Description
Potent and selective cannabinoid receptor type 1 (CB1) antagonist and/or inverse agonist
CB1 antagonist/inverse agonist
Chemical nameN-[(1S,2S)-3-(4-Chloro-phenyl)-2-(3-cyano-phenyl)-1-methyl-propyl]-2-methyl-2-(5-trifluoromethyl-pyridin-2-yloxy)-propionamide Parent CAS No.[701977-09-5] |
| 产品资料 |
